Literature DB >> 21905082

Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis.

Kristina Kakalacheva1, Michael A Maurer, Björn Tackenberg, Christian Münz, Nick Willcox, Jan D Lünemann.   

Abstract

Lymph node-type T- and B-cell infiltrates with germinal centers are characteristic features of the hyperplastic thymus in early onset myasthenia gravis (EOMG).Epstein-Barr virus (EBV) infection confers survival advantages on B cells, and has recently been implicated in tertiary lymphoid tissue formation in EOMG. We evaluated the frequency of intrathymic EBV-infected B-lineage cells and antiviral immune responses in treatment-naive patients with EOMG. Real-time polymerase chain reaction was performed to quantify the content of genomic EBV DNA (BamHI-W repeat region) in thymic cell suspensions. Serial paraffin sections of EOMG thymi were analyzed for the presence of EBV-encoded RNA by in situ hybridization and for viral gene expression by immunohistochemistry. Humoral and cellular immune responses to viral antigens were quantified by enzyme-linked immunosorbent assay and flow cytometry-based intracellular cytokine staining. We detected minimal levels of viral DNA-corresponding to single viral genomes-in only 6 of 16 hyperplastic EOMG thymi, indicating extreme rarity of viral copy numbers in the investigated thymic samples. That was confirmed by similar rarity of EBV-encoded RNA and viral proteins identified in thymic sections. Furthermore, EBV-specific T- and B-cell responses were unchanged in patients with EOMG. These findings do not support an etiologic role for EBV in the initiation of EOMG.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905082     DOI: 10.1002/ana.22488

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Detection of human polyomavirus 7 in human thymic epithelial tumors.

Authors:  Dorit Rennspiess; Sreedhar Pujari; Marlies Keijzers; Myrurgia A Abdul-Hamid; Monique Hochstenbag; Anne-Marie Dingemans; Anna Kordelia Kurz; Ernst-Jan Speel; Anke Haugg; Diana V Pastrana; Christopher B Buck; Marc H De Baets; Axel Zur Hausen
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 15.609

Review 2.  Myasthenia gravis and infectious disease.

Authors:  Nils Erik Gilhus; Fredrik Romi; Yu Hong; Geir Olve Skeie
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

3.  A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis.

Authors:  Victoria Leopardi; Yu-Mei Chang; Andrew Pham; Jie Luo; Oliver A Garden
Journal:  Front Neurol       Date:  2021-06-14       Impact factor: 4.003

Review 4.  Association between Epstein-Barr virus and Thymic epithelial tumors: a systematic review.

Authors:  Guofei Zhang; Zipu Yu; Gang Shen; Ying Chai; Chengxiao Liang
Journal:  Infect Agent Cancer       Date:  2019-11-06       Impact factor: 2.965

Review 5.  Myasthenia Gravis: An Acquired Interferonopathy?

Authors:  Cloé A Payet; Axel You; Odessa-Maud Fayet; Nadine Dragin; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Cells       Date:  2022-04-04       Impact factor: 6.600

Review 6.  The contribution of thymic tolerance to central nervous system autoimmunity.

Authors:  Piero Alberti; Adam E Handel
Journal:  Semin Immunopathol       Date:  2020-10-27       Impact factor: 9.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.